A&NN Group

A&NN Group, also referred to as A&NN Investments, is a Russian-focused investment holding and private equity firm rather than a life sciences, biotech, pharma, or healthcare operating company. Public business-directory and investor-profile sources describe it as an acquisition-oriented investment group founded in 2002 by Aleksandr Mamut, with activities spanning sectors such as consumer, media, technology, real estate, transportation, and other general business assets. The available evidence does not indicate that A&NN Group develops therapeutics, medical devices, diagnostics, or healthcare services as its core business. Accordingly, it should not be treated as a biotech pipeline company for analyst purposes. Any exposure to healthcare, if present at all, would likely be indirect through portfolio investments rather than through an in-house R&D pipeline.